Breaking News
Get 60% Off 0
🔴 Discover our Top 10 Stocks for H2 2026 in this week's FREE live webinar
Watch the webinar
Close

Lupin Ltd Future - Jul 26

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,485.60 +24.70    +1.00%
02:34:29 - Delayed Data.
  • Prev. Close: 2,460.90
  • Open: 2,470.20
  • Day's Range: 2,466.00 - 2,493.70
Type:  Stock Future
Market:  India
Underlying:  Lupin
Lupin 2,485.60 +24.70 +1.00%

LUPNc1:NS Overview

 
Lupin Ltd Future stock price live, this page displays NSE LUPNc1:NS stock exchange data. View the LUPNc1:NS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Lupin Ltd Future real time stock price chart below.

What Is the Lupin Ltd Future Stock Price Today?
The Lupin Ltd Future stock price today is 2,485.60.

What Is the Stock Symbol for Lupin Ltd Future?
The stock symbol for Lupin Ltd Future is "LUPNc1:NS."

What Stock Exchange Does Lupin Ltd Future Trade On?
Lupin Ltd Future is listed and trades on the NSE stock exchange.

Is Lupin Ltd Future a Good Stock to Buy?
Determining whether Lupin Ltd Future—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.

You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LUPNc1:NS quote. (ISIN: )
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close2,460.9
MonthJul 26
Tick Size0.05
Open2,470.2
Contract Size400 shares
Tick Value20
Day's Range2,466 - 2,493.7
Settlement TypeCash
Base SymbolN/A
52 wk Range1,846.5 - 2,514.9
Settlement Day07/28/2026
Point Value1 = ₹400
1-Year Change28.35%
Last Rollover Day06/30/2026
MonthsFGHJKMNQUVXZ
What is your sentiment on Lupin?
or
Vote to see community's results!

Lupin Ltd Future News


Lupin receives FDA approval for famotidine injection
Lupin receives FDA approval for famotidine injection By Investing.com - May 13, 2026

Lupin Limited (500257, NSE: LUPIN) announced it received U.S. Food and Drug Administration approval for its Abbreviated New Drug Application for Famotidine Injection USP, 20 mg/2...

Lupin Ltd Future Analysis


Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Buy Buy Buy Buy Buy
Technical Indicators Strong Buy Strong Buy Strong Buy Strong Buy Strong Buy
Summary Strong Buy Strong Buy Strong Buy Strong Buy Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Completed Patterns
Doji Star Bearish 1W 1 Jul 05, 2026
Three Inside Down 1D 2 Jul 13, 2026
Gravestone Doji 1W 3 Jun 21, 2026
Three Inside Up 1H 3 Jul 14, 2026 23:00
Engulfing Bearish 15 3 Jul 15, 2026 01:45

Lupin Ltd Future Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NSE 2,485.60 2,485.70 2,487.90 198,475 +1.00% INR 02:34:29  
  NSE 2,504.90 2,504.60 2,504.70 356,896 +1.45% INR 02:50:31  
  NSE 2,490.60 2,485.60 2,490.60 33,150 +1.10% INR 02:29:29  
  NSE 2,496.20 2,491.80 2,500.80 2,975 +0.86% INR 01:37:25  
  BSE 2,502.65 2,501.30 2,502.75 8,204 +1.34% INR 02:35:28  

Trending Stocks

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Canadian Natural 60.00 61.40 59.62 -0.95 -1.56% 15.33M 14/07  
  Air Canada 22.87 23.79 22.84 -0.81 -3.42% 2.23M 14/07  
  Toronto Dominion Bank 172.81 173.34 170.76 +2.12 +1.24% 10.35M  
  BCE Inc 29.81 30.25 29.73 -0.59 -1.94% 4.76M 14/07  
  TELUS 14.69 14.87 14.68 -0.22 -1.48% 5.24M 14/07  
  Bank of Nova Scotia 125.25 126.10 124.25 +0.78 +0.63% 2.98M 14/07  
  Keel Infra 6.30 6.66 6.23 +0.13 +2.11% 3.26M 14/07  
  Canadian Imperial Bank 166.68 168.28 165.97 +0.71 +0.43% 1.14M 14/07  
  MDA 47.66 47.91 45.42 +2.98 +6.67% 1.58M 14/07  
  Celestica Inc. 485.06 497.65 481.31 -3.46 -0.71% 197.30K  

Lupin Ltd Future Company Profile

IndustryPharmaceuticals
SectorHealthcare
Employees

24006

Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company also offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, women’s health, and central nervous system areas, as well as pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies. In addition, it focuses on various therapeutic spectrum, including rheumatology, oncology, neuroscience, and renal therapies. Further, the company is involved in the provision of diagnostics services, and digital healthcare services; and neuro rehabilition business. It operates through network consists of labs and collection centers. The company has a strategic collaboration with TB Alliance for the development and commercialization of the investigational drug Telacebec for the treatment of multiple mycobacterial diseases including tuberculosis (TB), leprosy, and buruli ulcer. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Lupin Futures Discussions

Write your thoughts about Lupin Ltd Future
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email